期刊
TOXICOLOGY LETTERS
卷 336, 期 -, 页码 50-56出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.toxlet.2020.10.009
关键词
Nerve agents; Soman; Seizure; Cerebral blood flow; MRI; Oxygenation; Organophosphate; Hemodynamics; Animal model; Metabolism
类别
资金
- Defence Research and Development Canada - Suffield Research Centre [W7702-155719/A]
- Brain Canada Platform Grant
Exposure to nerve agents can lead to debilitating neurological damage, especially without direct neuroprotection. Seizures induced by nerve agents may be the main contributor to neuropathology, highlighting the importance of addressing metabolic impairment and reduced blood supply in treatment.
Nerve agent exposure can cause debilitating neurological damage even with treatment. Currently accepted treatments involve attenuating the cholinergic crisis and seizure onset but do not focus directly on neuroprotection. Hence, there is a need for improved treatments to reduce neurological deficits. It is important to understand the pathophysiology of nerve agent mediated injury in order to identify effective treatment targets. Nerve agent-induced seizures are believed to be the main contributor to the neuropathology. Recently seizures have been shown to cause vascular changes that may actually attenuate neurological damage. This study evaluated the effect of soman-induced convulsive seizures on the relationship between CNS oxygen consumption and supply. To simultaneously assess changes in oxygenation and perfusion, rats were implanted with permanently fixed fiber-optic tissue oxygen sensing probes in the motor cortex and imaged with continuous arterial spin labelling MRI to measure cerebral blood flow. Baseline tissue oxygen tension (ptO(2)) and cerebral blood flow (CBF) were measured in isoflurane anaesthetized rats at least one day prior to soman or saline exposure. Rats were pretreated with HI-6 dimethansulfonate and atropine methyl nitrate (125 mg/kg and 20 mg/kg; intraperitoneal) followed by a convulsive dose of soman (90 mu g/kg; subcutaneous) or equal volume of saline. Three additional treatments of HI-6/AMN were administered to improve survival. At 1.5 -hs after exposure, ptO(2) and cerebral blood flow measurements were conducted. There was a significant decrease in CBF 1.5 -hs following soman exposure but no change in ptO(2) was found. When we correlated ptO(2) and CBF, for a given ptO(2), there was lower CBF following soman exposure. This may indicate metabolism is inhibited, possibly because of mitochondrial impairment, therefore reducing oxygen demand. These data show hypoperfusion in brain following soman exposure which would be expected to contribute to soman-related neuropathology. Crown Copyright (C) 2020 Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据